Beam Therapeutics Inc (BEAM) Stock to return to profitability in the near future
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Beam Therapeutics Inc (BEAM) Stock is the one stock you should own forever
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Why Beam Therapeutics Inc (NASDAQ:BEAM) Stock climbed 8.38% in Last Three Months?
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Beam Therapeutics Inc (NASDAQ:BEAM) stock is trading 94.93 percent above its 52-week low
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Beam Therapeutics Inc (BEAM) Stock is more thoughtful than you think
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Beam Therapeutics Inc (BEAM) Stock: Pessimism is a stepping stone to opportunity
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]
Beam Therapeutics Inc (BEAM) Stock to return to profitability in the near future
JP Morgan raised the price target for the Beam Therapeutics Inc (NASDAQ:BEAM) stock from “a Neutral” to “an Overweight”. The rating was released on January 29, 2024, according to finviz. The research report from Jefferies has downgraded the stock from Buy to Hold, with a price target set at $30. The stock was downgraded by […]